Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease patients and low bodyweight: results from KNOW-CKD study

Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease patients and low bodyweight: results from KNOW-CKD study

Abstract The benefits and risks of aspirin therapy for patients with chronic kidney disease (CKD) who have a high burden of cardiovascular events (CVE) are controversial. To examine the effects of low-dose aspirin on major clinical outcomes in patients with CKD. As a prospective observational cohort...

Full description

Bibliographic Details
Main Authors: Yun Jung Oh, Ae Jin Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung, Young Youl Hyun, Joongyub Lee, Yeong Hoon Kim, Seung Hyeok Han, Dong-Wan Chae, Curie Ahn, Kook-Hwan Oh, Ji Yong Jung
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-86192-4

Internet

https://doi.org/10.1038/s41598-021-86192-4

Similar Items